← Back to Clinical Trials
Recruiting NCT07877571

NCT07877571 Effectiveness of Health Communication on Depression Elderly in Ho Chi Minh City

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07877571
Status Recruiting
Phase —
Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Condition Depression - Major Depressive Disorder
Study Type INTERVENTIONAL
Enrollment 550 participants
Start Date 2026-06-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Health CommunicationHealth communication

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 550 participants in total. It began in 2026-06-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if a community-based health education and communication program helps prevent and reduce depression in older adults living in Ho Chi Minh City. It will also evaluate how the program affects quality of life and caregiver stress. The main questions it aims to answer are: 1. Does the health education program improve knowledge, attitudes, and practice regarding depression among older adults and their primary caregivers? 2. Does the program reduce depression scores (measured by GDS-30) and improve quality of life in older adults compared to standard care? 3. Does the program help lower caregiving burden and stress among primary caregivers? Researchers will compare an intervention group (older adult and caregiver pairs who receive the education program) to a control group (pairs who receive standard community health care). Participants in the intervention group will: * Attend 5 group education sessions (45-60 minutes each) covering early depression detection, sleep hygiene, nutrition, physical activity, stress management, and caregiver support. * Complete questionnaires at the start and end of the program to measure depression symptoms, quality of life, caregiving burden, and health knowledge.

Eligibility Criteria

Inclusion Criteria for Older Adults * Aged 60 years or older. * Currently residing in Ho Chi Minh City, with continuous residence in the locality for at least 6 months. * Willing and agreeing to participate in the study (informed consent provided). Inclusion Criteria for Primary Caregivers * Role: Serving as the primary person responsible for and/or providing the most support to the older adult in activities of daily living (ADLs) (e.g., eating, personal hygiene, mobility) and/or providing emotional support and healthcare management (e.g., medication adherence, accompanying to medical appointments). * Duration: Having performed this caregiving role for at least 6 consecutive months (to ensure adequate observation time and caregiving burden experience). * Frequency: Living in the same household with the older adult, or, if residing separately, having direct contact and providing care on most days of the week. * Aged 18 years or older, with full legal capacity, and capable of hearing, understanding, and self-completing the survey questionnaire. * Identified as the primary caregiver of an older adult who has already met the inclusion criteria and agreed to participate in the study. * Voluntarily agreeing to participate in the study after receiving a detailed explanation of the study objectives and signing the Informed Consent Form (ICF). * Note: In cases where no family caregiver is identified during the survey phase, professional/paid caregivers (e.g., formal nurses or hired aides employed specifically for caregiving tasks without family ties to the older adult) will be considered. Exclusion Criteria for Older Adults * Temporary residents or individuals absent from the study area during the study period. * Individuals with severe cognitive impairment or lack of mental capacity to complete the questionnaire. * Individuals with acute medical conditions in severe/critical stages, those diagnosed with other psychiatric disorders, or those uncooperative during the study process. Exclusion Criteria for Primary Caregivers * Refusal to participate or lacking capacity to complete the interview due to severe cognitive impairment, dementia, or severe psychiatric disorders. * Currently suffering from severe physical or mental health deterioration (e.g., undergoing emergency medical treatment, severe fever) that significantly impairs their ability to respond to the interview.

Contact & Investigator

Central Contact

Diep Le Tuan, Psychiatrist

✉ letuan.vatc@gmail.com

📞 +84 775525532

Frequently Asked Questions

Who can join the NCT07877571 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07877571 currently recruiting?

Yes, NCT07877571 is actively recruiting participants. Contact the research team at letuan.vatc@gmail.com for enrollment information.

Where is the NCT07877571 trial being conducted?

This trial is being conducted at Ho Chi Minh City, Vietnam.

Who is sponsoring the NCT07877571 clinical trial?

NCT07877571 is sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. The trial plans to enroll 550 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology